Toggle navigation
Home
Search
Services
Blog
Contact
About
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A.
Alexion Pharmaceuticals, Inc., Cheshire, CT, United States
Search 17 grants from Scott Rollins
Search grants from Alexion Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of California San Diego
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Long-lasting consequences of early ethanol on network activity during sleep
VA-Perry Point Cooperative Studies Program
Immunological Candidate Genes for Iddm Susceptibility
Gene Regulation During Fungal Development
Lipoprotein Subfractions & Chd During 25 Yr Follow-Up
Recently added grants:
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus
Identification of preclinical drug candidates for the treatment of schistosomiasis
Antibody therapy of MRSA colonization and infection
Interspecies chimera libraries to define host specific adaptations by Chlamydia
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052365-03
Application #
2029136
Study Section
Special Emphasis Panel (ZRG4-HEM-2 (02))
Project Start
1994-09-30
Project End
1997-08-31
Budget Start
1996-09-05
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Alexion Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Cheshire
State
CT
Country
United States
Zip Code
06410
Related projects
NIH 1996
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
NIH 1995
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
Comments
Be the first to comment on Scott Rollins's grant